June 2022 Legislative & Regulatory Briefing; ICYMI: Come (Learn) PIE with Me eLearning Days Webinar; AMCP Joins Pharmacy Stakeholders Advocating for PHEPharmacy Staffing Flexibility; [Blog] Why PIE and the Prescription Digital TherapeuticsAct Matter: Recap of AMCP Legislative Days.
May 2022 Legislative & Regulatory Briefing; ICYMI: AMCP Policy & Government Relations Agenda Webinar; AMCP Officially Named Healthy People 2030 Champion; ICYMI: Come (Learn) PIE with Me eLearning Days Webinar.
March 2022 Legislative & Regulatory Briefing; AMCP Legislative Agenda 2022 and Beyond Webinar –Thursday, April 7; AMCP Signals Support for Legislative Priorities; AMCP Supports Authorization for Pharmacists to OrderCOVID-19 Antivirals; AMCP Responds to Part D Proposed Rule; AMCP is a Healthy People 2030 Champion.
June 2022 News & Views: There’s Still Time to Register for the AMCP Summit and Corresponding Satellite Symposia; Partnership Forum Summary on High Investment Medications Now Available; View the Updated Pharmacy Pay-for-PerformancePrinciples.
In 2016, AMCP made pre-approval information exchange (PIE) a legislative priority recognizing its vital importance to patients. On June 8, 2022, the U.S. House of Representatives passed the PIE Act of 2022. Learn more about PIE as a legislative priority for AMCP.
Partnership Forum: This forum identified challenges and payer needs related to the evidence for digital therapeutics. The forum explored the current market space for digital therapeutics including the evidence for the products, place in therapy, monitoring or utilization metrics and barriers that patients face in obtaining therapies.